Go KCL

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

DRUG STUDY

Patient’s Initials: J,B. Date of Admission:___________ Diagnosis:___________________________________________________________


Age: Height: cm Weight.: kg Clinical Intervention: Used to treat or prevent low amounts of potassium in the blood.
Sex: female Ward: VND Bed No.: 301E Name of Physician: _____________________________

Drug Information Classification Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities

Generic Name: Pharmacologi Pharmacodynamics General The use of CNS Before Drug Administration:
Potassium Chloride c or Mechanism of Indication/s: Potassium Chloride - Confusion ● Conduct a thorough history to identify
Classification Action: The use of is contraindicated in - Restlessness any relevant drug allergies.
Trade Name: : Potassium the instance of: - Weakness ● Confirm the patient's status through
- Kaligen Potassium- Maintain acid-base Chloride is - Paresthesia laboratory results, including blood
- K-lyte containing balance,isotonicity indicated for: ● Hypersensitivity tests.
- Kalium preparations and electrophysiologic to potassium Cardiovascular System: ● Obtain baseline vital signs.
- Kaliusaphride balance of the cell. (1) Electrolyte chloride or - Arrhythmias, ● Be cautious of look-alike sound
- K tab Therapeutic Activator in many replenisher components of - ECG changes situations with potassium
Classification: enzymatic reactions; and in the the formulation - Hypotension preparations; ensure verification of
Electrolyte essential to treatment of the correct product before usage and
Minimum Dose: supplement transmission of hypokalemia. ● Patients with Gastrointestinal System avoid switching between products.
40 mEq in 2 divided nerve impulses; renal failure, and - Abdominal pain
doses daily Pregnancy contraction of Patient’s in those with - Diarrhea During Drug Administration:
Category cardiac, skeletal, Indication: conditions in - Flatulence ● Double-check and validate the
Maximum Dose: Risk: C and smooth muscle; - treatment of which potassium - Nausea doctor's order.
200 mEq daily gastric secretion; renal hypokalemia retention is - Vomiting, ● Administer medication with or after
function; tissue present - GI ulceration meals, accompanied by a full glass of
Patient’s Dose: synthesis; and water or fruit juices to prevent
10 mEq tablet/ 1 tab carbohydrate ● Use cautiously Others gastrointestinal distress.
TID metabolism. in patients with Hyperkalemia ● Instruct the patient not to chew tablets
cardiac disease, but to swallow them whole.
Route: Oral renal
impairment,and After Drug Administration:
acid base
disorders. ● Document the procedure accurately.
● Monitor vital signs regularly.
● Educate the patient and their
significant other about potential side
effects.
Certification Date: 1 SDF-CON-304-071-00
February 2021
Recertification due
Page 1 of 5
date: 24 January 2024
For verification of the
certificate please
access
www.gcl-intl.com
(Certification check
and type the
registration number)
Pharmacokinetics: ● Encourage them to promptly report
Frequency: Interactions any abnormalities such as weakness,
● TID Excretion nausea, or vomiting.
Renal Captopril: The risk ● Inform the patient about the possibility of
Availability/Form: or severity of detecting wax matrix in stool, indicating
Extended release Half-life hyperkalemia can drug absorption.
tablets 8 hours be increased when
☐ 8 mEq Potassium chloride
☐ 10 mEq Onset is combined with
☐ 20 mEq 60 minutes Captopril.

Peak Carvedilol: May


Contents: 4 hours increase the
One sugar-coated hyperkalemic
tablet contains 600 mg Duration activities of
potassium chloride as 24-48 hours
active substance
equivalent to 8 mmol
potassium ion (K+).
Excipients: Each tablet
contains 96.4mg
sucrose
Student Name: Go, Ishi Nadine R. Year/Section: 3A Date: ______________ Score: /30
Directions: Please select the appropriate rating using the following descriptions.

Very Satisfactory Satisfactory Needs Improvement Comments


☐ Accurately presented all of the patient ☐ Accurately presented most of the ☐ Accurately presented some of the patient
Drug
and drug information (name [brand & generic], patient and drug information related to the and drug information related to the case. 2 or more
Information
dosage case. 1 missing information or error noted. [2] missing information or errors noted. [1]
(10%)
[patient’s dose; min. & max], frequency, route,
availability, contents) related to the case. [3]
☐ Accurately presented the classification ☐ Accurately presented the classification ☐ Inaccurately presented the classification related
Classification
(therapeutic and pharmacologic) related to the related to the drug but with 1 irrelevant to the drug. Classification is not relevant to the
(10%)
drug. [3] information or error noted. [2] drug. [1]
☐ Accurately presented the indication/s ☐ Accurately presented the indication/s related ☐ Inaccurately presented the indication/s related
Indication (10%) (general & patient-specific) related to the drug. [3] to the drug but with 1 irrelevant information or to the drug. Indication is not relevant to the drug. [1]
error noted. [2]
☐ Accurately presented the mechanism of action ☐ Accurately presented the mechanism of ☐ Inaccurately presented the mechanism of action
Mechanism of
(pharmacokinetics, pharmacodynamics) of the action of the drug but with 1 irrelevant of the drug. Mechanism of action is not relevant to
Action (10%)
drug. [3] information or error noted. [2] the drug. [1]
☐ Accurately presented all of the common ☐ Accurately presented most of the common ☐ Accurately presented some of the common
Contraindication
contraindications related to the drug. [3] contraindications related to the drug. 1 missing contraindications related to the drug. 2 or more
(10%)
information or error noted. [2] missing information or errors noted. [1]
☐ Accurately presented all of the common ☐ Accurately presented most of the common ☐ Accurately presented some of the common side
Side Effects
side effects related to the drug. [3] side effects related to the drug. 1-2 missing effects related to the drug. 3 or more missing
(10%)
information or errors noted. [2] information or errors noted. [1]
Nursing ☐ Accurately presented all of the common ☐ Accurately presented most of the common ☐ Accurately presented some of the common
Responsibilities nursing responsibilities (before, during, and after) nursing responsibilities related to the drug. 1-2 nursing responsibilities related to the drug. 3 or
(30%) related to the drug. [9] missing information or errors noted. [7] more missing information or errors noted. [3]
☐ Presented at least 2 sources that are ☐ Presented only one source that is ☐ No source was presented. Sources are not
References updated (within 5 years), relevant, and credible. updated (within 5 years), relevant, and credible. updated (more than 5 years), relevant, and
(10%) [3] Other credible. [1]
sources are not updated, credible or relevant. [2]
Sub-score = = =

You might also like